HEALTHSTREAM INC (HSTM)
HEALTHSTREAM INC (HSTM)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 5,910 | 2,534 | 6,087 | 9,721 |
| Depreciation and amortization | 11,365 | 11,037 | 10,820 | 21,621 |
| Stock-based compensation | 1,309 | 5,411 | 794 | 1,940 |
| Amortization of deferred commissions | 3,286 | 3,443 | 3,173 | 6,017 |
| Provision for credit losses | 92 | 440 | 177 | 391 |
| Deferred income taxes | 0 | 62 | 4,588 | 467 |
| Loss on equity method investments | -40 | -40 | -43 | -107 |
| Change in fair value of non-marketable equity investments | NaN | 0 | NaN | NaN |
| Other | 160 | 169 | 370 | 776 |
| Accounts and unbilled receivables | 4,550 | 5,016 | 2,432 | -3,465 |
| Prepaid royalties | 1,695 | -1,910 | NaN | NaN |
| Other prepaid expenses and other current assets | -2,300 | 2,693 | -1,548 | 1,728 |
| Other assets | 2,611 | 7,385 | 3,285 | 8,596 |
| Accounts payable and accrued expenses | -7,044 | 6,613 | -1,334 | -3,858 |
| Accrued royalties | 994 | -48 | 819 | -366 |
| Deferred revenue | 17,900 | -2,987 | -2,598 | 3,692 |
| Net cash provided by operating activities | 27,136 | 13,192 | 18,030 | 32,097 |
| Cash paid for acquisitions | 302 | 35,091 | NaN | NaN |
| Proceeds from maturities of marketable securities | 13,400 | 10,800 | 15,213 | 26,073 |
| Proceeds from sale of marketable securities | NaN | 9,770 | NaN | NaN |
| Purchases of marketable securities | 10,197 | 2,062 | 15,334 | 26,100 |
| Proceeds from sale of non-marketable equity investments | NaN | 0 | 0 | 0 |
| Proceeds from sale of fixed assets | NaN | 41 | NaN | NaN |
| Purchases of other investments | 1,750 | 0 | 1,000 | 500 |
| Payments associated with capitalized software development | 6,727 | 6,568 | 7,410 | 14,500 |
| Purchases of property and equipment | 740 | 204 | 109 | 3,372 |
| Net cash used in investing activities | -6,316 | -23,314 | -8,640 | -18,399 |
| Taxes paid related to net settlement of equity awards | 582 | 1,320 | 121 | 1,075 |
| Payment of debt issuance costs | NaN | 0 | NaN | NaN |
| Payment of cash dividends | 1,028 | 920 | 919 | 1,890 |
| Repurchases of common stock | 6,723 | 5,004 | 6,897 | 18,121 |
| Net cash used in financing activities | -8,333 | -7,244 | -7,937 | -21,086 |
| Effect of exchange rate changes on cash and cash equivalents | 63 | -17 | -11 | 21 |
| Net increase in cash and cash equivalents | 12,550 | -17,383 | 1,442 | -7,367 |
| Cash and cash equivalents at beginning of period | 36,161 | 53,544 | 59,469 | NaN |
| Cash and cash equivalents at end of period | 48,711 | 36,161 | 53,544 | NaN |